VYGR
Voyager Therapeutics, Inc.
CIK 0001640266 · Biological Products, (No Diagnostic Substances)
Z″ LOWER ZONE
Z′ -2.02
Net margin
-296.5%
as of 2025-12-31
Operating margin
-326.6%
as of 2025-12-31
Revenue YoY growth
-49.5%
as of 2025-12-31
Provenance: VYGR’s most recent Revenue
$40,374,000
- Filing
- 0001104659-26-025197 (10-K)
- Period
- 2025-01-01 to 2025-12-31
- XBRL tag
- us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Context
- Duration_1_1_2025_To_12_31_2025_BqZt0Aq7yEimth5iO7Ljbw
- Mapping
- seed · confidence 1.00